Revance Therapeutics Inc (RVNC)

[vinmantoo]

The deal is subject to regulatory approvals and other conditions and is anticipated to close by the end of 2024.

This statement and the frequent very short term extensions to the tender date make me suspect that there will be a definitive result before the end of this month. … and it’s not likely to make the current shareholders very happy.

How many times are you going to repeat the same sentiment? We get it, you hate RVNC and feel anyone holding shares is naive and foolish. Sheesh. Give it a rest.